Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells

  • Authors:
    • J. H.J. Martin
    • A. Symonds
    • S. Chohan
  • View Affiliations

  • Published online on: July 1, 2003     https://doi.org/10.3892/or.10.4.979
  • Pages: 979-984
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We investigated the effect of tamoxifen, 4-OH tamoxifen, toremifene droloxifene, interferon-α2a, interferon-α2b and interferon-α2c, singly and in combination, for their effect on nitric oxide production by MCF-7 and ZR-75-1 human breast cancer cells. Tamoxifen and 4-OH tamoxifen singly had no effect on nitric oxide production by either cell line. However, treatment with droloxifene or toremifene significantly reduced nitric oxide production by both MCF-7 and ZR-75-1 human breast cancer cell lines. Combination treatment with anti-estrogens and interferon-α2a interferon-α2b or interferon-α2c had no synergistic or additive effect compared to each drug singly.

Related Articles

Journal Cover

July-August 2003
Volume 10 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Martin JH, Symonds A and Chohan S: Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells. Oncol Rep 10: 979-984, 2003.
APA
Martin, J.H., Symonds, A., & Chohan, S. (2003). Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells. Oncology Reports, 10, 979-984. https://doi.org/10.3892/or.10.4.979
MLA
Martin, J. H., Symonds, A., Chohan, S."Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells". Oncology Reports 10.4 (2003): 979-984.
Chicago
Martin, J. H., Symonds, A., Chohan, S."Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells". Oncology Reports 10, no. 4 (2003): 979-984. https://doi.org/10.3892/or.10.4.979